Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
10x Genomics, Inc. (TXG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 3,757 shares
@ $45.7811, valued at
$172k
|
|
| 08/24/2023 |
4
| McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,678 shares
@ $45.7811, valued at
$76.8k
|
|
| 08/24/2023 |
4
| Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 9,699 shares
@ $45.7811, valued at
$444k
|
|
| 08/24/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 3,449 shares
@ $45.7811, valued at
$157.9k
|
|
| 08/16/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,983 shares
@ $50.1033, valued at
$99.4k
Sold 17 shares
@ $50.42, valued at
$857.1 |
|
| 08/03/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,727 shares
@ $61.7714, valued at
$106.7k
Sold 5,243 shares
@ $62.3561, valued at
$326.9k
Exercised 6,970 options to buy
@ $11.48, valued at
$80k
|
|
| 08/03/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2023 |
SC 13G/A
| MORGAN STANLEY reports a 5.2% stake in 10x Genomics, Inc. |
| 07/10/2023 |
SC 13G/A
| FMR LLC reports a 12.7% stake in 10X GENOMICS INC |
| 06/16/2023 |
4
| ROBERTS BRYAN E (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/16/2023 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/16/2023 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/16/2023 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/16/2023 |
4
| Mammen Mathai (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/16/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 06/16/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Gifted 185 shares
@ $0
Sold 740 shares
@ $57.5038, valued at
$42.6k
Sold 1,209 shares
@ $58.5262, valued at
$70.8k
Sold 51 shares
@ $59.15, valued at
$3k
|
|
| 06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/07/2023 |
4
| STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 10,000 shares
@ $54.8894, valued at
$548.9k
|
|
| 05/25/2023 |
4
| Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 243 shares
@ $55.0594, valued at
$13.4k
Sold 619 shares
@ $55.0605, valued at
$34.1k
Sold 735 shares
@ $55.0631, valued at
$40.5k
Sold 791 shares
@ $55.0612, valued at
$43.6k
|
|
| 05/25/2023 |
4
| Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 316 shares
@ $55.0653, valued at
$17.4k
|
|
| 05/25/2023 |
4
| McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 194 shares
@ $55.0695, valued at
$10.7k
Sold 465 shares
@ $55.0621, valued at
$25.6k
Sold 441 shares
@ $55.0641, valued at
$24.3k
Sold 565 shares
@ $55.0637, valued at
$31.1k
|
|
| 05/23/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Gifted 460 shares
@ $0
Sold 534 shares
@ $55.064, valued at
$29.4k
Sold 2,068 shares
@ $55.0613, valued at
$113.9k
|
|
| 05/19/2023 |
4
| ROBERTS BRYAN E (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Converted 3,790,422 shares
@ $0
Converted 3,790,422 options to buy
@ $0 |
|
| 05/17/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/17/2023 |
4
| Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 494 shares
@ $52.6971, valued at
$26k
Sold 1,506 shares
@ $53.5652, valued at
$80.7k
|
|
| 05/15/2023 |
4
| Mammen Mathai (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 33,000 shares
@ $52.8208, valued at
$1.7M
Exercised 200,000 options to buy
@ $1.16, valued at
$232k
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|
|
|